荻原広一郎

オギハラコウイチロウ | Ogihara Koichiro

所属機関・部署：
職名：共同研究員
競争的資金等の研究課題 (2件)：

2021 - 2023 CD44v陽性癌幹細胞モデルを基盤とした新規膀胱内注入療法の確立
2017 - 2019 膀胱癌における癌幹細胞の制御を標的とした新規治療戦略の確立

論文 (48件)：

Minami Omura, Eiji Kikuchi, Keisuke Shigeta, Koichiro Ogihara, Kyohei Hakozaki, Satoshi Hara, Suguru Shirotake, Hiroki Ide, Shunsuke Yoshimine, Takashi Ohigashi, et al. Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer. Japanese journal of clinical oncology. 2022. 52. 4. 388-396
Hiroki Ide, Eiji Kikuchi, Koichiro Ogihara, Naoya Niwa, Keisuke Shigeta, Tsukasa Masuda, Yuto Baba, Ryuichi Mizuno, Mototsugu Oya. Urinary pH is an independent predictor of upper tract recurrence in non-muscle-invasive bladder cancer patients with a smoking history. Scientific Reports. 2021. 11. 1
Tetsushi Murakami, Eiji Kikuchi, Hiroki Ide, Yuta Umezawa, Takayuki Takahashi, Mizuki Izawa, Kyohei Hakozaki, Keisuke Shigeta, Koichiro Ogihara, Hiroaki Kobayashi, et al. Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma. BJUI Compass. 2021. 2. 5. 322-330
Ryohei Kufukihara, Eiji Kikuchi, Koichiro Ogihara, Keisuke Shigeta, Mototsugu Oya. ASO Author Reflections: Previous History of Non-urothelial Malignancy May Provide Predictive Information of Worse Clinical Outcome for Initially Diagnosed Non-Muscle Invasive Bladder Cancer. Annals of surgical oncology. 2021. 28. 9. 5360-5361
Yuto Baba, Eiji Kikuchi, Keisuke Shigeta, Koichiro Ogihara, Masashi Matsushima, Yui Nishimoto, Yasuaki Murata, Hirotaka Asakura, Masafumi Oyama, Ryuichi Mizuno, et al. Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer. International journal of clinical oncology. 2021. 26. 11. 2094-2103

MISC (23件)：

久冨木原良平, 菊地栄次, 菊地栄次, 茂田啓介, 荻原広一郎, 有田祐起, 秋田大宇, 鈴木達也, 水野隆一, 大家基嗣, et al. 膀胱癌の筋層浸潤評価におけるVI-RADSと膀胱鏡検査の役割. 泌尿器画像診断・治療技術研究会プログラム・抄録. 2021. 8th
Koichiro Ogihara, Eiji Kikuchi, Takashi Okabe, Ryo Yamashita, Shunsuke Yoshimine, Suguru Shirotake, Ryuto Nakazawa, Kazuhiro Matsumoto, Ryuichi Mizuno, Satoshi Hara, et al. PRETREATMENT ABSOLUTE MONOCYTE COUNT IS A NOVEL BIOMARKER FOR PREDICTING WORSE CLINICAL OUTCOME IN CHEMO-RESISTANT UROTHELIAL CARCINOMA PATIENTS TREATED WITH PEMBROLIZUMAB. JOURNAL OF UROLOGY. 2020. 203. E741-E742
Koichiro Ogihara, Eiji Kikuchi, Toshikazu Takeda, Kazuhiro Matsumoto, Hideyuki Saya, Mototsugu Oya. SULFASALAZINE COULD MODULATE THE CD44V9-XCT SYSTEM AND ENHANCE CDDP-INDUCED CYTOTOXIC EFFECTS IN METASTATIC BLADDER CANCER; A NOVEL THERAPEUTIC STRATEGY FOR METASTATIC BLADDER CANCER. JOURNAL OF UROLOGY. 2020. 203. E2-E2
Tadatsugu Anno, Eiji Kikuchi, Koichiro Ogihara, Mototsugu Oya. SITE SPECIFIC DIFFERENCES IN SURVIVAL AMONG BLADDER, RENAL PELVIC, AND URETERAL UROTHELIAL CARCINOMA PATIENTS TREATED WITH RADICAL SURGERY. JOURNAL OF UROLOGY. 2019. 201. 4. E720-E720
Shigeta Keisuke, Eiji Kikuchi, Masayuki Hagiwara, Takayuki Abe, Koichiro Ogihara, Ryuichi Mizuno, Mototsugu Oya. SIMULATING THE SURVEILLANCE DURATION OF INTRAVESICAL RECURRENCE AFTER RADICAL NEPHROURETERECTOMY: AN INDIVIDUALIZED RISK BASED APPROACH APPLYING THE WEIBULL MODEL. JOURNAL OF UROLOGY. 2019. 201. 4. E717-E717

学歴 (2件)：

2016 - 2020 慶應義塾大学医学研究科
2003 - 2009 慶應義塾大学医学部

学位 (1件)：

博士 (慶應義塾大学)

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

荻原 広一郎

荻原広一郎